The Legal 500: Pharmaceutical Advertising Comparative Guide 2022

The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The aim of this guide is to provide its readers with a pragmatic overview of the law and practice of pharmaceutical advertising law across a variety of jurisdictions.

Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.

The Q&A template for each chapter has been provided by Sally Shorthose.

Read our overview of Pharmaceutical Advertising laws and regulations applicable in:

Read the French chapter here
Read the German chapter here
Read the UK chapter here

Latest insights

More Insights
Birds on a beach

Court grants relief from liability to Block Earner - ASIC appeals

Jun 21 2024

Read More
Bank card propped up against laptop

Market review into card scheme and processing fees – PSR’s interim report and provisional findings

Jun 20 2024

Read More
glass building

Flexible Amendment to the Czech Labour Code

Jun 20 2024

Read More